Private biotech funding has skyrocketed, so why bother going public? – MedCity News https://t.co/orh1lUzWDb
— The Propell Group (@ThePropellGroup) December 29, 2016
#healthtech
Private biotech funding has skyrocketed, so why bother going public? – MedCity News https://t.co/orh1lUzWDb
— The Propell Group (@ThePropellGroup) December 29, 2016
#healthtech